Ihr Broker

  • Sonderkonditionen
  • Mehrfach reguliert
  • Sehr finanzstark
  • Reguliert in CYPERN & Australien

Mehr Erfahren >>

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

trading-house Börsenakademie

Gemeinsam erfolgreich

MARKETS.COM
QIAGEN N.V., NL0012169213

QIAGEN N.V., NL0012169213

11.06.2019 - 18:03:19

QIAGEN N.V.: Release of a capital market information

Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated EU Regulation 2016/1052 / Share Repurchase - Interim Reporting

With disclosure dated May 10, 2019, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no 2016/1052 the immediate beginning of a fourth tranche of up to USD 50 million under the share repurchase program originally announced on January 31, 2018.

The number of shares which have been bought back on the electronic trading platform of the Frankfurt Stock Exchange (XETRA) within the framework of such tranche of the share repurchase program in the time period from June 3, 2019 until and including June 7, 2019 amounts to 88,904 shares.

Shares were bought back as follows:

Date Number of Shares Average Price Purchased Volume acquired (EUR) (EUR) 3 June 2019 22,568 34.0747 768,997.83 4 June 2019 16,812 33.8441 568,987.01 5 June 2019 16,602 34.2713 568,972.12 6 June 2019 16,447 34.6554 569,977.36 7 June 2019 16,475 34.5969 569,983.93 Total 88,904 34.2720 3,046,918.25

The underlying individual trades are published on the website of QIAGEN N.V. (http://corporate.qiagen.com/investor-relations/share-information/ share-buyback).

The total number of shares which have already been bought back within the framework of such tranche of the share repurchase program from May 10, 2019 until and including June 7, 2019 amounts to 693,458 shares.

The purchase of the shares of QIAGEN N.V. was carried out by a financial institution that has been commissioned by QIAGEN N.V.

Venlo, 11 June 2019

Managing Board

### Contacts:

QIAGEN Investor Relations John Gilardi +49 2103 29 11711 e-mail: ir@qiagen.com

Public Relations Dr. Thomas Theuringer +49 2103 29 11826 e-mail: pr@qiagen.com

11.06.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: QIAGEN N.V. Hulsterweg 82 5912 PL Venlo

Netherlands Internet: www.qiagen.com   End of News DGAP News Service

822731  11.06.2019 

@ dgap.de